Prostate Cancer - Results from #22380

Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancer - Abstract August 29, 2013

Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: Retrospective analysis of safety profile and effect on blood coagulation - Abstract August 29, 2013

Prostate-specific antigen testing: Men's responses to 2012 recommendation against screening - Abstract August 29, 2013

Expert opinion on chemotherapy use in castration-resistant prostate cancer progressing after docetaxel - Abstract August 29, 2013

New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical - Abstract August 29, 2013

Improving the Gleason grading accuracy of transrectal ultrasound-guided biopsy - Abstract August 29, 2013

PSA-based screening for prostate cancer: A comparative analysis - Abstract August 29, 2013

The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: The North Carolina-Louisiana Prostate Cancer Project - Abstract August 29, 2013

The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy - Abstract August 29, 2013

Prostate volumetric assessment by magnetic resonance imaging and transrectal ultrasound: Impact of variation in calculated prostate-specific antigen density on patient eligibility for active surveillance program - Abstract August 29, 2013

A pilot study of Laparoscopic Doppler ultrasound probe to map arterial vascular flow within the neurovascular bundle during robot-assisted radical prostatectomy - Abstract August 28, 2013

Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer - Abstract August 28, 2013

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer - Abstract August 28, 2013

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml - Abstract August 28, 2013

Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease - Abstract August 28, 2013

Safe introduction of robot-assisted radical prostatectomy after a training program in a high-volume robotic centre - Abstract August 28, 2013

New radiation treatment for prostate cancer reduces bone pain, extends survival rates August 28, 2013

Four or more cups of coffee a day may keep prostate cancer recurrence and progression away August 28, 2013

Prevention and detection of prostate cancer: A pilot intervention in a resource-poor South African community - Abstract August 27, 2013

Subcutaneous infusion in palliative care: The neria soft infusion set - Abstract August 27, 2013

Page 1120 of 1435